Biotech Stocks Rally on Positive Clinical Data and Earnings Updates

Wednesday, Jan 7, 2026 10:19 pm ET1min read
ACRV--
ALXO--
GMED--

Several biotech and healthcare companies posted notable gains in after-hours trading, driven by clinical updates, financial results, and upcoming industry presentations. ALX Oncology Holdings surged 10.17% after announcing positive data from a Phase 2 trial of its lead candidate. Globus Medical climbed 9.34% after releasing preliminary unaudited sales results, with full-year 2025 sales expected to reach $2.936 billion. Acrivon Therapeutics rose 6.44% after announcing plans to release clinical data updates.

Biotech Stocks Rally on Positive Clinical Data and Earnings Updates

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet